Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homeopathy as a protective factor against COVID-19
RBR-84nk5q6Phase 3Completed
- Sponsor
- Universidade Federal de Mato Grosso do Sul
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Arsenicum album with Placebo (2 arms). Primary endpoint: Efficacy and safety of homeopathic prophylaxis against COVID-19. Started Nov 2020; status: completed.
02
Drugs
arsenicum album
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-84nk5q6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-84nk5q6.